These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34652958)

  • 1. Incidence, Treatment, and Outcome of HIV-Associated Hematologic Malignancies in People Living with HIV in Sweden.
    Kieri O; Marrone G; Sönnerborg A; Nowak P
    AIDS Res Hum Retroviruses; 2022 Feb; 38(2):135-142. PubMed ID: 34652958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study.
    Hoffmann C; Hentrich M; Gillor D; Behrens G; Jensen B; Stoehr A; Esser S; van Lunzen J; Krznaric I; Müller M; Oette M; Hensel M; Thoden J; Fätkenheuer G; Wyen C
    HIV Med; 2015 Apr; 16(4):261-4. PubMed ID: 25252101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.
    Shepherd L; Ryom L; Law M; Hatleberg CI; de Wit S; Monforte AD; Battegay M; Phillips A; Bonnet F; Reiss P; Pradier C; Grulich A; Sabin C; Lundgren J; Mocroft A
    J Natl Cancer Inst; 2018 Jun; 110(6):598-607. PubMed ID: 29267895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukine-2 therapy does not increase the risk of Hodgkin or non-Hodgkin lymphoma in HIV-infected patients: results from FHDH ANRS CO4.
    Fontas E; Kousignian I; Pradier C; Duvivier C; Poizot-Martin I; Durier C; Jarrousse B; Weiss L; Levy Y; Costagliola D;
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):206-14. PubMed ID: 19131886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing Patterns of Lymphoma in the Antiretroviral Therapy Era in Johannesburg, South Africa.
    Wiggill T; Mayne E; Perner Y; Vaughan J
    J Acquir Immune Defic Syndr; 2021 Nov; 88(3):252-260. PubMed ID: 34354010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics, incidence, and risk factors of HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy.
    Gotti D; Danesi M; Calabresi A; Ferraresi A; Albini L; Donato F; Castelli F; Scalzini A; Quiros-Roldan E;
    AIDS Patient Care STDS; 2013 May; 27(5):259-65. PubMed ID: 23600703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
    Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
    Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998.
    Glaser SL; Clarke CA; Gulley ML; Craig FE; DiGiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
    Cancer; 2003 Jul; 98(2):300-9. PubMed ID: 12872349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family history of hematopoietic malignancy and risk of lymphoma.
    Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
    J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007.
    Seaberg EC; Wiley D; Martínez-Maza O; Chmiel JS; Kingsley L; Tang Y; Margolick JB; Jacobson LP;
    Cancer; 2010 Dec; 116(23):5507-16. PubMed ID: 20672354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era.
    Gopal S; Patel MR; Yanik EL; Cole SR; Achenbach CJ; Napravnik S; Burkholder GA; Reid EG; Rodriguez B; Deeks SG; Mayer KH; Moore RD; Kitahata MM; Eron JJ; Richards KL
    J Natl Cancer Inst; 2013 Aug; 105(16):1221-9. PubMed ID: 23892362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer risk in people infected with human immunodeficiency virus in the United States.
    Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
    Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case-control study of HIV infection and cancer in the era of antiretroviral therapy in Rwanda.
    Mpunga T; Znaor A; Uwizeye FR; Uwase A; Munyanshongore C; Franceschi S; Clifford GM
    Int J Cancer; 2018 Sep; 143(6):1348-1355. PubMed ID: 29663358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cohort profile: InfCareHIV, a prospective registry-based cohort study of people with diagnosed HIV in Sweden.
    Carlander C; Brännström J; Månsson F; Elvstam O; Albinsson P; Blom S; Mattsson L; Hovmöller S; Norrgren H; Mellgren Å; Svedhem V; Gisslén M; Sönnerborg A
    BMJ Open; 2023 Mar; 13(3):e069688. PubMed ID: 36931676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
    Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
    Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignancies in HIV-infected children at Siriraj Hospital.
    Sanpakit K; Veerakul G; Kriengsuntornkij W; Chokephaibulkit K; Tanphaichitr VS; Mahasandana C
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S542-8. PubMed ID: 12403230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ and CD8+ T-cell kinetics in aviremic HIV-infected patients developing Hodgkin or non-Hodgkin lymphoma.
    Hoffmann C; Schommers P; Wolf E; Müller M; Schultze A; Krznaric I; Stoehr A; Wolf T; Fäktenheuer G; Stier B; Wyen C; Hentrich M
    AIDS; 2016 Mar; 30(5):753-60. PubMed ID: 26605513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longer duration of combination antiretroviral therapy reduces the risk of Hodgkin lymphoma: A cohort study of HIV-infected male veterans.
    Kowalkowski MA; Mims MA; Day RS; Du XL; Chan W; Chiao EY
    Cancer Epidemiol; 2014 Aug; 38(4):386-92. PubMed ID: 24947588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation, treatment, and outcomes among 65 patients with HIV-associated lymphoma treated at the University of North Carolina, 2000-2010.
    Gopal S; Martin KE; Richards KL; Eron JJ
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):798-805. PubMed ID: 22011066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing HIV and Hodgkin lymphoma in the twenty-first century.
    Aries J; Montoto S
    Curr Hematol Malig Rep; 2014 Sep; 9(3):227-32. PubMed ID: 24906351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.